A selection of synthetic organic positions:
Conformetrix, a biotechnology company in Manchester, is recruiting medicinal chemists. Established as a spin-out from the University of Manchester in 2008, Conformetrix uses proprietary NMR-based technology to solve bioactive 3D structures of molecules, allowing it to develop its own drug portfolio and to partner with pharma companies. This appears to be an ideal opportunity for an experienced medicinal chemist, with at least 5 years’ experience at an influential project level and a strong publication record, to join a rapidly growing biotech. More information on the company can be found on their website.
Syngenta are recruiting synthetic and medicinal chemists at their Jeallot’s Hill site, near Bracknell. Working in the herbicide research group, the role involves the design and synthesis of new compounds as potential agrochemicals. BSC/MChem/PhD or relevant synthetic experience required; experience with a wide range of purification and analytical techniques essential.
A number of positions are available this month at Cancer Research Technology, a subsidiary of Cancer Research UK. Three medicinal chemists - two permanent, one 12-month contract – are sought, to develop novel cancer therapies. Jobs will be based in either Cambridge or Central London. BSc with medchem experience, or MSc/PhD with synthetic organic or medchem specialisation required.
A principal scientist medical chemist is additionally required in Central London to lead the design and synthesis of novel chemotherapeutics. Qualifications as per the junior role, with at least 5 years’ pharma understanding – preferably in oncology – and demonstrated line and project management skills.
Finally, MSD in Hertfordshire are looking for a process chemist to carry out the range of activities from process development to large-scale processing, to deliver active pharmaceutical ingredients. PhD with postdoc experience required. Apply by 18th April.
No comments:
Post a Comment
Note: only a member of this blog may post a comment.